comparemela.com

Latest Breaking News On - Optibiotix health plc - Page 7 : comparemela.com

Investegate |OptiBiotix Health Announcements | OptiBiotix Health: Director dealing

Investegate |OptiBiotix Health Announcements | OptiBiotix Health: Director dealing
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |OptiBiotix Health Announcements | OptiBiotix Health: Director s Dealing

Investegate |OptiBiotix Health Announcements | OptiBiotix Health: Director s Dealing
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines OptiBiotix reports group net profit of £5 8 million

By BFN News | 08:42 AM | Thursday 18 February, 2021 Biotech company OptiBiotix has reported a net profit of in the 12 months of the financial year ending 31 December 2020, driven by growing sales and larger margins. Group net profit for the year was approximately £5.8 million, subject to auditing. OptiBiotix s Functional Fibres division delivered an EBITDA of £66,271, up from an EBITDA loss of £433,249 in 2019, with total sales of £5.5 million, an increase in sales of 151% over 2019. ProBiotix, an entirely owned subsidiary, delivered an EBITDA of £75,768, up from an EBITDA loss of £474,205 in 2019, with total sales of £818,481. Stephen O Hara, CEO of OptiBiotix, commented: ?This has been another year of progress for OptiBiotix with its probiotic and functional fibre divisions achieving profitability by doubling sales, improving margins, and reducing costs, in a very challenging and uncertain global economic environment.

Human Microbiome Market Analysis with Research Report 2021 |OptiBiotix Health Plc, Metabiomics, OSEL Inc , PureTech Health

OptiBiotix to jointly research affect of products on sleep, anxiety | 11 January 2021

11 January 2021 | 09:51am StockMarketWire.com - Dietary supplements group OptiBiotix Health said it had agreed to jointly fund and carry out a research project examining the role of its microbiome products to improve sleep, stress, and anxiety. The project partners included Fondazione Edmund Mach - Centro Ricerca e Innovazione, based in Trento, Italy, and the University of Southampton. The research would be performed in the School of Human Development and Health at the University of Southampton and include funding for a related PhD studentship. It would include a double blind, placebo controlled, human study carried out during a period of stress induced sleep disruption.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.